看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。. v5 N! u) R( T9 J( z5 n$ W
r( [/ \7 {/ m$ E8 t
# v7 T: Z$ t5 Y% b8 F- t8 o
Currently available feasibility data for possible combination strategies. ' ~1 A9 d5 o% W" [8 K" X; [6 n
————————————————————————————————! E6 ~; B9 \& t, o* _% t1 P& `
Combination Feasibility according to preliminary data
; h1 `( I1 V6 i: x- @——————————————————————————————————, N. |; @$ U: q; b% }* e, n
Bevacizumab + sorafenib Yes, reduced dose " }% O s! l) ~! @8 Q
Bevacizumab + sunitinib† No
* W% k4 ~7 |6 DBevacizumab + temsirolimus Yes
3 P& x q1 h8 U- MBevacizumab + everolimus Yes
8 {1 S# [, W2 h' aSorafenib + sunitinib ? ; R8 p S/ h k; v
Sorafenib + temsirolimus Yes, reduced dose |+ K* Q: W+ V3 M
Sorafenib + everolimus Yes, reduced dose
' T7 p3 y/ [8 I" Z9 CSunitinib + temsirolimus† No 4 K# c2 u# Z' j! S! m5 n7 @7 U
Sunitinib + everolimus ?
% v# p5 n7 g6 q6 yTemsirolimus + everolimus ? }- q0 u6 ^- z' z8 g% t: ?
————————————————————1 z+ [7 |: \# z. d% S
†Led to US FDA warning.
/ X- g6 x$ Y! a2 Q% n) N, L: M& x?: As yet unattempted combination.
; E. m: a+ ?: O" R: H |